Web3 Watch – 1 Feb 24
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BoJ’s Takata calls for nimble, data-dependent rate hikes rather than a fixed pace
AI Infrastructure Stocks Shed $4.2 Trillion—Is the “Shovel Seller Feast” Over?
Since June, Caterpillar has dropped by 44%, and Oklo has plummeted by 49%. Analysts point to the root cause: investors have been speculating on traditional industrial stocks as growth stocks, resulting in severely overvalued prices. Another key factor behind the sell-off is the uncertainty of data center regulatory policies following the U.S. midterm elections. The fundamentals remain resilient—Caterpillar has a backlog of orders totaling $78 billion, and several companies have secured revenue growth through 2027.

Johnson & Johnson (JNJ.US) plans to spend $3.4 billion to acquire Ollin, expanding its presence in the retinal disease treatment sector.
According to sources familiar with the matter, Johnson & Johnson may announce a deal as early as Monday to acquire Texas-based biotech company Ollin Biosciences for up to $3.4 billion.

